By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cequent Pharmaceuticals, Inc. 

One Kendall Square
Building 700, First Floor
Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-995-7940 Fax: 617-995-7941


SEARCH JOBS



Segment
Start Up





Company News
MDRNA, Inc. Shareholders Approve Acquisition of Cequent Pharmaceuticals, Inc. 7/22/2010 10:12:32 AM
Cequent Pharmaceuticals, Inc. Announces European Patent Office Intent to Grant and Korean Patent Office Notice of Decision to Award First Patents Covering tkRNAi Therapeutics 6/22/2010 11:44:29 AM
Cequent Pharmaceuticals, Inc. Begins Chronic Toxicology Study with CEQ508, Lead Oncology tkRNAi Drug Candidate 4/15/2010 10:23:08 AM
MDRNA, Inc. to Buy Privately Held Cequent Pharmaceuticals, Inc. for $46 Million 4/1/2010 6:29:58 AM
FDA Grants Cequent Pharmaceuticals, Inc. IND 12/10/2009 11:25:26 AM
Cequent Pharmaceuticals, Inc. Files its First IND with FDA: CEQ508, a tkRNAi Drug Candidate in Oncology First Orally Delivered RNAi Investigational Drug to be Tested in Humans 11/12/2009 8:46:29 AM
Cequent Pharmaceuticals, Inc. Closes Tranche of $10.8 Million Round 11/2/2009 8:04:11 AM
Cequent Pharmaceuticals, Inc. to Provide Details at BIOCOM About Planned Launch of its Clinical Program 10/13/2009 8:43:10 AM
Cequent Pharmaceuticals, Inc. Names F. Stephen Laroux, Ph.D., Director, Immunology and Inflammatory Diseases 6/2/2009 11:42:33 AM
Cequent Pharmaceuticals, Inc. tkRNAi Technology to be Presented at the Centennial Meeting of the American Association for Cancer Research 4/16/2009 11:51:10 AM
123
//-->